Omniox


Omniox is an IND-stage biotherapeutics company focused on developing innovative H-NOX platform technology into first-in-class and best-in-class OMX oxygen delivery vehicles. These biologics are designed to safely deliver oxygen to hypoxic tissues, addressing significant unmet medical needs and improving patient outcomes.

Omniox Logo

Omniox

181 2nd Street, San Francisco, CA 94105, USA


Patents

Modulation of tumor immunity by protein-mediated O2 delivery

2025-04-29 • US-12285463-B2

View Details

Polymeric forms of H-NOX proteins

2024-05-21 • US-11987614-B2

View Details

Polymeric forms of H-NOX proteins

2021-09-14 • US-11117952-B2

View Details

Polymeric forms of H-NOX proteins

2020-09-08 • US-10766947-B2

View Details

Polymeric forms of H-NOX proteins

2019-08-20 • US-10385116-B2

View Details

What We Do

OMX Oxygen Delivery Vehicles

OMX biologics engineered to deliver oxygen safely to hypoxic tissues, restoring normal tissue function and improving patient outcomes.



Key People

Jonathan Winger, PhD

Co-Founder and CEO

Julia Simmons

Senior Director, Controller

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.